Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Rx “Benefits”: Drug Industry, PBMs Expected To Prosper

Executive Summary

The possibility of a Medicare drug benefit leading to price controls is remote, Uwe Reinhardt, PhD, Princeton University, maintained during a Charles Schwab Capital Markets conference in Washington, D.C. Oct. 29

You may also be interested in...

PBMs, Pharmacies Can Cooperate To Defend Private Health Care, PCMA Says

Pharmacy benefit managers, retail pharmacies and drug manufacturers should work together to prevent government intervention in the health care industry, Pharmacy Care Management Association CEO Mark Merritt told the association's annual meeting Oct. 27 in Indian Wells, Calif

Medicare Rx Benefit Costs Will Exceed $400 Bil. – Rep. Waxman

Medicare drug benefit legislation will ultimately cost well over the $400 bil. budget target, Rep. Henry Waxman (D-Calif.) predicted Oct. 29

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts